{"transactions":[{"id":1035125,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Strategy & Transformation"}}],"security":"Common Stock","published_at":"2025-09-22T20:14:04.000Z","date":"2025-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":958,"price":7.77,"value":7443.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025."}],"balance_after":127726,"source":{"system":"sec-edgar","filing":"0001843568-25-000006","document":"wk-form4_1758572042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356825000006/wk-form4_1758572042.xml","form_type":"4"}},{"id":1192732,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:25.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1904,"price":10.01,"value":19059.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":128684,"source":{"system":"sec-edgar","filing":"0001628280-25-014730","document":"wk-form4_1742933838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014730/wk-form4_1742933838.xml","form_type":"4"}},{"id":1192731,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:25.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":718,"price":10.01,"value":7187.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":130588,"source":{"system":"sec-edgar","filing":"0001628280-25-014730","document":"wk-form4_1742933838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014730/wk-form4_1742933838.xml","form_type":"4"}},{"id":1204849,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-17T20:20:31.000Z","date":"2025-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1572,"price":10.07,"value":15830.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":131306,"source":{"system":"sec-edgar","filing":"0001628280-25-013153","document":"wk-form4_1742242824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013153/wk-form4_1742242824.xml","form_type":"4"}},{"id":1204848,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-17T20:20:31.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":3417,"price":10.07,"value":34409.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":132878,"source":{"system":"sec-edgar","filing":"0001628280-25-013153","document":"wk-form4_1742242824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013153/wk-form4_1742242824.xml","form_type":"4"}},{"id":1204847,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-17T20:20:31.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":54124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":136295,"source":{"system":"sec-edgar","filing":"0001628280-25-013153","document":"wk-form4_1742242824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013153/wk-form4_1742242824.xml","form_type":"4"}},{"id":1232258,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-05T00:31:50.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":6468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025."}],"balance_after":82171,"source":{"system":"sec-edgar","filing":"0001628280-25-010139","document":"wk-form4_1741134703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025010139/wk-form4_1741134703.xml","form_type":"4"}},{"id":1244201,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-02-26T21:24:46.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2697,"price":11.74,"value":31662.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2025."}],"balance_after":75703,"source":{"system":"sec-edgar","filing":"0001843568-25-000002","document":"wk-form4_1740605078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356825000002/wk-form4_1740605078.xml","form_type":"4"}},{"id":1401198,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2024-09-23T20:17:27.000Z","date":"2024-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":966,"price":27.64,"value":26700.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 20, 2024."}],"balance_after":78400,"source":{"system":"sec-edgar","filing":"0001843568-24-000006","document":"wk-form4_1727122641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356824000006/wk-form4_1727122641.xml","form_type":"4"}},{"id":1424627,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2024-08-23T20:16:32.000Z","date":"2024-08-21","kind":"sale","planned":false,"acquired":false,"shares":11538,"price":27.82,"value":320987.16,"ownership":{"direct":true},"balance_after":79366,"source":{"system":"sec-edgar","filing":"0001843568-24-000004","document":"wk-form4_1724444186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356824000004/wk-form4_1724444186.xml","form_type":"4"}},{"id":1562552,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:51.000Z","date":"2024-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":730,"price":22.24,"value":16235.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":90904,"source":{"system":"sec-edgar","filing":"0001628280-24-012918","document":"wk-form4_1711398698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012918/wk-form4_1711398698.xml","form_type":"4"}},{"id":1573565,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:59.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1585,"price":21.16,"value":33538.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024."}],"balance_after":91634,"source":{"system":"sec-edgar","filing":"0001628280-24-011686","document":"wk-form4_1710794750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011686/wk-form4_1710794750.xml","form_type":"4"}},{"id":1573564,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:59.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":35178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":93219,"source":{"system":"sec-edgar","filing":"0001628280-24-011686","document":"wk-form4_1710794750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011686/wk-form4_1710794750.xml","form_type":"4"}},{"id":1620562,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2024-02-26T21:09:56.000Z","date":"2024-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":2231,"price":22.72,"value":50688.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 23, 2024."}],"balance_after":58041,"source":{"system":"sec-edgar","filing":"0001843568-24-000002","document":"wk-form4_1708981775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356824000002/wk-form4_1708981775.xml","form_type":"4"}},{"id":1775055,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2023-09-22T20:31:34.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":60272,"source":{"system":"sec-edgar","filing":"0001843568-23-000004","document":"wk-form4_1695414680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356823000004/wk-form4_1695414680.xml","form_type":"4"}},{"id":1940675,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2023-03-23T20:29:46.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":751,"price":22.91,"value":17205.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023."}],"balance_after":50272,"source":{"system":"sec-edgar","filing":"0001628280-23-009054","document":"wf-form4_167960337427659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009054/wf-form4_167960337427659.xml","form_type":"4"}},{"id":1950945,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2023-03-16T20:32:28.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":16419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":51023,"source":{"system":"sec-edgar","filing":"0001628280-23-008325","document":"wf-form4_167899873690419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023008325/wf-form4_167899873690419.xml","form_type":"4"}},{"id":1991326,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2023-02-27T21:11:22.000Z","date":"2023-02-25","kind":"tax_withholding","acquired":false,"shares":2556,"price":18.54,"value":47388.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 24, 2023."}],"balance_after":34604,"source":{"system":"sec-edgar","filing":"0001843568-23-000001","document":"wf-form4_167753224751902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356823000001/wf-form4_167753224751902.xml","form_type":"4"}},{"id":2320471,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-23T21:01:39.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":9754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":37160,"source":{"system":"sec-edgar","filing":"0001843568-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356822000004/edgardoc.xml","form_type":"4"}},{"id":2370063,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-28T21:58:21.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":2594,"price":24.69,"value":64045.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person on February 18, 2021. The restricted stock units granted on February 18, 2021 represent a contingent right to receive one share of the Company's common stock and vested 25% on February 25, 2022 and vests 25% on February 25, 2023, 25% on February 25, 2024, and 25% on February 25, 2025. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2022."}],"balance_after":27406,"source":{"system":"sec-edgar","filing":"0001843568-22-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356822000002/edgardoc.xml","form_type":"4"}},{"id":2844357,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Enterprise Transformation"}}],"security":"Common Stock","published_at":"2021-02-22T21:43:43.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on February 18, 2022, 25% on February 18, 2023, 25% on February 18, 2024, and 25% on February 18, 2025."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001843568-21-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356821000006/edgardoc.xml","form_type":"4"}}]}